Pharmaceutical Holding & Subsidiaries

A United Structure, Driving Healthcare Innovation Forward

Arena Life Science Holding was established to build an integrated ecosystem in the pharmaceutical and healthcare industry. By combining innovation, expertise, and strategic investments, the holding oversees a group of specialized subsidiaries that cover the entire pharmaceutical value chain — from research and manufacturing to import, export, marketing, and distribution.

Role of the Holding

Arena Life Science Holding provides strategic direction and coordination for its subsidiaries by:

Driving innovation and R&D in pharmaceuticals and biotechnology.
Ensuring compliance and quality across all operations.
Managing strategic investments to expand product portfolios and market reach.
Creating synergies among subsidiaries to maximize efficiency and value.

Our Subsidiary Companies

Arena Pharmaceuticals

Focused on manufacturing and developing innovative medicines, including generics and biotechnology-based products.

Arena Trading & Importation

Responsible for global sourcing and importation of raw materials and specialty medicines to meet domestic healthcare needs.

Arena Marketing & Distribution

Handles sales, marketing, and nationwide distribution, ensuring patient access to safe and effective medicines.

Arena Biotechnology

Dedicated to recombinant proteins and biologics, leading research projects and clinical studies in high-tech pharmaceuticals.

Arena Research & Development

The scientific backbone of the holding, investing in new projects, regulatory approvals, and clinical research to strengthen innovation.

Shared Vision

Each subsidiary plays a vital role in achieving the holding’s shared vision:

Innovation

Developing advanced pharmaceutical solutions.

Accessibility

Ensuring medicines are available and affordable to patients.

Accessibility

Ensuring medicines are available and affordable to patients.

Growth

Expanding regionally and internationally through sustainable strategies.